{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:32:55Z","timestamp":1791261175777,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Kelly Group"},{"name":"King's College Hospital Charity"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jhepr.2020.100149","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T03:53:06Z","timestamp":1595303586000},"page":"100149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Approach to the patient with acute severe autoimmune hepatitis"],"prefix":"10.1016","volume":"2","author":[{"given":"Mussarat N.","family":"Rahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Heneghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"Lohse","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib3","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.25551","article-title":"Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011","volume":"55","author":"Lee","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100149_bib4","first-page":"282","article-title":"The management of fulminant hepatic failure","volume":"3","author":"Trey","year":"1970","journal-title":"Prog Liver Dis"},{"issue":"8866","key":"10.1016\/j.jhepr.2020.100149_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0140-6736(93)91818-7","article-title":"Acute liver failure: redefining the syndromes","volume":"342","author":"Williams","year":"1993","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1440-1746.1999.01905.x","article-title":"Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure","volume":"14","author":"Tandon","year":"1999","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib8","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib9","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/lt.25451","article-title":"Acute severe autoimmune hepatitis: corticosteroids or liver transplantation?","volume":"25","author":"Rahim","year":"2019","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jhep.2014.05.021","article-title":"Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome","volume":"61","author":"Yeoman","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jhep.2016.03.023","article-title":"Usefulness of corticosteroids as first-line therapy in patients with acute severe autoimmune hepatitis","volume":"65","author":"Moenne-Loccoz","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100149_bib12","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/lt.21036","article-title":"Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis","volume":"13","author":"Ichai","year":"2007","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cgh.2006.10.011","article-title":"Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis","volume":"5","author":"Abe","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib15","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jhep.2012.06.026","article-title":"Acute-on chronic liver failure","volume":"57","author":"Jalan","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1478-3231.2012.02790.x","article-title":"A\u00a0systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality","volume":"33","author":"Wlodzimirow","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2020.100149_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5108781","article-title":"Bacterial infection and predictors of mortality in patients with autoimmune liver disease-associated acute-on-chronic liver failure","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.30205","article-title":"Flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy","volume":"70","author":"Anand","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100149_bib20","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib21","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.21884","article-title":"The impact of ethnicity on the natural history of autoimmune hepatitis","volume":"46","author":"Verma","year":"2007","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jhepr.2020.100149_bib22","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2018.11.028","article-title":"Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis","volume":"17","author":"de Boer","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/hepr.13252","article-title":"Prompt initiation of high-dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis","volume":"49","author":"Zachou","year":"2019","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000487940","article-title":"Corticosteroid therapy improves the outcome of autoimmune hepatitis-induced acute liver failure","volume":"98","author":"Anastasiou","year":"2018","journal-title":"Digestion"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0016-5085(99)70458-0","article-title":"Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis","volume":"117","author":"Czaja","year":"1999","journal-title":"Gastroenterology"},{"issue":"38","key":"10.1016\/j.jhepr.2020.100149_bib26","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.3748\/wjg.v11.i38.6069","article-title":"Autoimmune hepatitis triggered by acute hepatitis A","volume":"11","author":"Tanaka","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0168-8278(95)80336-X","article-title":"Autoimmune hepatitis following hepatitis A virus infection","volume":"23","author":"Huppertz","year":"1995","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.jhepr.2020.100149_bib28","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/BF01537282","article-title":"Autoimmune chronic active hepatitis developing after acute type B hepatitis","volume":"34","author":"Laskus","year":"1989","journal-title":"Dig Dis Sci"},{"issue":"8751","key":"10.1016\/j.jhepr.2020.100149_bib29","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0140-6736(91)92858-Y","article-title":"Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals","volume":"337","author":"Vento","year":"1991","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib30","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1053\/jhep.2001.24562","article-title":"Protracted, but not acute, hepatitis a virus infection is strongly associated with HLA-DRB1\u22171301, a marker for pediatric autoimmune hepatitis","volume":"33","author":"Fainboim","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000082253","article-title":"Autoimmune hepatitis - sequel of a relapsing hepatitis A in a 75-year-old woman","volume":"70","author":"Gr\u00fcnhage","year":"2004","journal-title":"Digestion"},{"issue":"8549","key":"10.1016\/j.jhepr.2020.100149_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(87)93051-0","article-title":"Persistent measles virus GENOME IN autoimmune chronic active hepatitis","volume":"2","author":"Robertson","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib33","doi-asserted-by":"crossref","first-page":"e228433","DOI":"10.1136\/bcr-2018-228433","article-title":"Autoimmune liver disease following acute hepatitis A infection","volume":"12","author":"Yeend-Curd-Trimble","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3349\/ymj.2020.61.1.100","article-title":"Autoimmune hepatic failure following acute hepatitis a is accompanied by inflammatory conversion of regulatory T cells","volume":"61","author":"Leem","year":"2020","journal-title":"Yonsei Med J"},{"issue":"13","key":"10.1016\/j.jhepr.2020.100149_bib35","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3748\/wjg.v24.i13.1410","article-title":"Potential triggering factors of acute liver failure as a frst manifestation of autoimmune hepatitis-a single center experience of 52 adult patients","volume":"24","author":"Buechter","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100149_bib36","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","article-title":"ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury","volume":"109","author":"Chalasani","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib37","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","author":"Andrade","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4254\/wjh.v6.i4.160","article-title":"Drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease","volume":"6","author":"Castiella","year":"2014","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2011.02.024","article-title":"Drug induced liver injury and its relationship to autoimmune hepatitis","volume":"55","author":"Weiler-Normann","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib40","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis vs. drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib41","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/ijc.30678","article-title":"Risk of hepatotoxicity in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis of published data","volume":"141","author":"Wang","year":"2017","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.jhepr.2020.100149_bib42","first-page":"760","article-title":"Hepatotoxicity after immune checkpoint inhibitor therapy in melanoma\u202f:natural progression and management","volume":"41","author":"Huffman","year":"2018","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"issue":"8","key":"10.1016\/j.jhepr.2020.100149_bib43","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s10620-012-2140-5","article-title":"Pathologic changes in ipilimumab-related hepatitis in patients with metastatic melanoma","volume":"57","author":"Kleiner","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1016\/j.jhepr.2020.100149_bib44","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/PAS.0000000000000453","article-title":"Ipilimumab-associated hepatitis: clinicopathologic characterization in a series of 11 cases","volume":"39","author":"Johncilla","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib45","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2018.01.033","article-title":"Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors","volume":"68","author":"De Martin","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib46","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/liv.13746","article-title":"Hepatotoxicity of immune checkpoint inhibitors: an evolving picture of risk associated with a vital class of immunotherapy agents","volume":"38","author":"Suzman","year":"2018","journal-title":"Liver Int"},{"issue":"11","key":"10.1016\/j.jhepr.2020.100149_bib47","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41424-018-0072-x","article-title":"Immune checkpoint inhibitor-associated colits and hepatitis","volume":"9","author":"Reddy","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib48","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41379-018-0013-y","article-title":"Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury","volume":"31","author":"Zen","year":"2018","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12072-018-9921-7","article-title":"Liver damage related to immune checkpoint inhibitors","volume":"13","author":"Nishida","year":"2019","journal-title":"Hepatol Int"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100149_bib50","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1634\/theoncologist.2018-0174","article-title":"Diagnosis and management of hepatitis in patients on checkpoint blockade","volume":"23","author":"Reynolds","year":"2018","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib51","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/MEG.0000000000000353","article-title":"Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure","volume":"27","author":"Mendizabal","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jhbp.326","article-title":"Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure","volume":"23","author":"Fujiwara","year":"2016","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib53","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"EASL clinical practice guidelines on hepatitis E virus infection","volume":"68","author":"Dalton","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib54","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/liv.14332","article-title":"Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: role of false-positive antibodies","volume":"40","author":"Llovet","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2020.100149_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpeds.2018.12.042","article-title":"Corticosteroid therapy for indeterminate pediatric acute liver failure and Aplastic anemia with acute hepatitis","volume":"208","author":"Chapin","year":"2019","journal-title":"J\u00a0Pediatr"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100149_bib56","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41395-018-0160-2","article-title":"Acute liver failure of indeterminate etiology: a comprehensive systematic approach by an expert committee to establish causality","volume":"113","author":"Ganger","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.jhepr.2020.100149_bib57","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/apt.14566","article-title":"Systematic review: non A-E, seronegative or indeterminate hepatitis; what is this deadly disease?","volume":"47","author":"Brennan","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MPG.0000000000000593","article-title":"Fulminant hepatic failure of autoimmune aetiology in children","volume":"60","author":"Di Giorgio","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib59","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jhep.2007.05.011","article-title":"The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study","volume":"47","author":"Bernal","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.jhepr.2020.100149_bib60","doi-asserted-by":"crossref","first-page":"E141","DOI":"10.1111\/hepr.12483","article-title":"Severe and fulminant hepatitis of indeterminate etiology in a Japanese center","volume":"45","author":"Fujiwara","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2020.100149_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3513206","article-title":"Clinical and pathological characteristics of autoimmune hepatitis with acute presentation","volume":"2018","author":"Shen","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib62","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/MCG.0000000000000805","article-title":"Natural history and treatment outcomes of severe autoimmune hepatitis","volume":"51","author":"Sonthalia","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib63","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cgh.2008.08.043","article-title":"Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis","volume":"7","author":"Mehendiratta","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib64","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-010-1501-1","article-title":"Performance parameters of the conventional serological markers for autoimmune hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.jhepr.2020.100149_bib65","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00535-008-2254-x","article-title":"Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis","volume":"43","author":"Fujiwara","year":"2008","journal-title":"J\u00a0Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib66","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00535-010-0316-3","article-title":"Clinicopathological features of severe and fulminant forms of autoimmune hepatitis","volume":"46","author":"Yasui","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"issue":"11","key":"10.1016\/j.jhepr.2020.100149_bib67","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1023\/B:DDAS.0000004522.36120.08","article-title":"Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates","volume":"48","author":"Loria","year":"2003","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100149_bib68","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease","volume":"99","author":"Adams","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jhepr.2020.100149_bib69","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00535-005-1711-z","article-title":"Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?","volume":"40","author":"Yatsuji","year":"2005","journal-title":"J\u00a0Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13317-013-0046-7","article-title":"Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis","volume":"4","author":"Himoto","year":"2013","journal-title":"Autoimmun Highlights"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib71","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1872-034X.2011.00892.x","article-title":"Importance of computed tomography imaging features for the diagnosis of autoimmune acute liver failure","volume":"42","author":"Yasui","year":"2012","journal-title":"Hepatol Res"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100149_bib72","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/liv.13725","article-title":"Clinical and prognostic associations of liver volume determined by computed tomography in acute liver failure","volume":"38","author":"Zabron","year":"2018","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"10.1016\/j.jhepr.2020.100149_bib74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000440747","article-title":"Role of histopathology in autoimmune hepatitis","volume":"33","author":"Tiniakos","year":"2015","journal-title":"Dig Dis"},{"issue":"10","key":"10.1016\/j.jhepr.2020.100149_bib75","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1111\/j.1572-0241.2002.06052.x","article-title":"Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature","volume":"97","author":"Singh","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100149_bib76","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis","volume":"2","author":"Kessler","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib77","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00000478-200404000-00006","article-title":"Autoimmune hepatitis with centrilobular necrosis","volume":"28","author":"Misdraji","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.jhepr.2020.100149_bib78","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1872-034X.2007.00125.x","article-title":"Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis","volume":"37","author":"Miyake","year":"2007","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib79","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1386-6346(02)00274-7","article-title":"Clinicopathological features of acute-onset autoimmune hepatitis","volume":"25","author":"Okano","year":"2003","journal-title":"Hepatol Res"},{"issue":"11","key":"10.1016\/j.jhepr.2020.100149_bib80","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/jclinpath-2016-204271","article-title":"Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients","volume":"70","author":"Nguyen Canh","year":"2017","journal-title":"J\u00a0Clin Pathol"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib81","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.2005.029348","article-title":"Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation","volume":"59","author":"Hofer","year":"2006","journal-title":"J\u00a0Clin Pathol"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100149_bib82","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4254\/wjh.v4.i9.262","article-title":"Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis","volume":"4","author":"Abe","year":"2012","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib83","first-page":"11","article-title":"Detection of early zone 3 liver fibrosis in chronic alcoholics a comparison of four connective tissue staining methods","volume":"95","author":"Vyberg","year":"1987","journal-title":"Acta Pathol Microbiol Scand Ser A Pathol"},{"issue":"10","key":"10.1016\/j.jhepr.2020.100149_bib84","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1039\/C9AN00267G","article-title":"Nonlinear microscopy of common histological stains reveals third harmonic generation harmonophores","volume":"144","author":"Kazarine","year":"2019","journal-title":"Analyst"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib85","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.semdp.2018.10.003","article-title":"Diagnostic histochemistry in hepatic pathology","volume":"35","author":"Iezzoni","year":"2018","journal-title":"Semin Diagn Pathol"},{"issue":"3-4","key":"10.1016\/j.jhepr.2020.100149_bib86","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.semdp.2006.11.006","article-title":"Special stains in diagnostic liver pathology","volume":"23","author":"Lefkowitch","year":"2006","journal-title":"Semin Diagn Pathol"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib87","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2559.1980.tb02943.x","article-title":"Hepatic fibrosis and collapse: histological distinction by orcein staining","volume":"4","author":"Scheuer","year":"1980","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib88","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1478-3231.2007.01466.x","article-title":"Special stains can distinguish hepatic necrosis with regenerative nodules from cirrhosis","volume":"27","author":"Ferrell","year":"2007","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100149_bib89","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1478-3231.2011.02524.x","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis","volume":"31","author":"Fujiwara","year":"2011","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib90","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease","volume":"50","author":"Yeoman","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib91","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.2016.267","article-title":"Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the International Autoimmune Hepatitis Group and proposal for new histologic criteria","volume":"30","author":"Balitzer","year":"2017","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.jhepr.2020.100149_bib92","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1007\/s10620-017-4728-2","article-title":"Treatment response and outcome with two different prednisolone regimens in autoimmune hepatitis","volume":"62","author":"Purnak","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1016\/j.jhepr.2020.100149_bib93","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared","volume":"16","author":"Summerskill","year":"1975","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib94","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gut.21.1.78","article-title":"Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis","volume":"21","author":"Kirk","year":"1980","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib95","first-page":"339","article-title":"Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience","volume":"39","author":"Kanzler","year":"2001","journal-title":"Z\u00a0Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib96","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jhep.2017.11.020","article-title":"Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis","volume":"68","author":"Hartl","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.jhepr.2020.100149_bib97","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.cgh.2018.12.035","article-title":"Predniso(lo)ne dosage and chance of remission in patients with autoimmune hepatitis","volume":"17","author":"Pape","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib98","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in\u00a0a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"issue":"52","key":"10.1016\/j.jhepr.2020.100149_bib99","doi-asserted-by":"crossref","first-page":"e18313","DOI":"10.1097\/MD.0000000000018313","article-title":"The Efficacy and safety of different doses of Glucocorticoid for autoimmune hepatitis: a systematic review and meta-analysis","volume":"98","author":"Zhang","year":"2019","journal-title":"Med"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib100","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.22894","article-title":"Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes","volume":"49","author":"Verma","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib101","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","article-title":"Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis","volume":"53","author":"Yeoman","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib102","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2015.04.032","article-title":"The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable","volume":"63","author":"De Martin","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100149_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(17)30270-2","article-title":"Treatment and prognosis of acute severe autoimmune hepatitis","author":"De Martin","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.jhepr.2020.100149_bib104","first-page":"S14","article-title":"Clinical epidemiology of fulminant hepatitis in Japan","volume":"38","author":"Takikawa","year":"2008","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib105","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.26678","article-title":"Steroid use in acute liver failure","volume":"59","author":"Karkhanis","year":"2014","journal-title":"Hepatology"},{"issue":"Suppl 11","key":"10.1016\/j.jhepr.2020.100149_bib106","first-page":"278","article-title":"Fulminant autoimmune hepatitis: clinical presentation, outcome and\u00a0prognostic factors (Abstract 480)","volume":"5","author":"Villamil","year":"2005","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100149_bib107","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2006.02894.x","article-title":"Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases","volume":"23","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib108","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease","volume":"46","author":"Montano-Loza","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib109","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0016-5085(88)90503-3","article-title":"Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis","volume":"95","author":"Czaja","year":"1988","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40261-017-0505-4","article-title":"Effect of N-acetylcysteine on mortality and liver transplantation rate in non-acetaminophen-induced acute liver failure: a multicenter study","volume":"37","author":"Darweesh","year":"2017","journal-title":"Clin Drug Investig"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib111","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.clinre.2015.01.003","article-title":"Efficacy and safety of acetylcysteine in \u201cnon-acetaminophen\u201d acute liver failure: a meta-analysis of prospective clinical trials","volume":"39","author":"Hu","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100149_bib112","first-page":"1","article-title":"Efficacy and safety of N-acetylcysteine in patients with non-acetaminophen-induced acute liver failure: a meta-analysis","volume":"13","author":"Aguila","year":"2019","journal-title":"Abstracts. Hepatol Int"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib113","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","article-title":"Intravenous N-acetylcysteine improves transplant-free survival in early\u00a0stage non-acetaminophen acute liver failure","volume":"137","author":"Lee","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib114","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s10620-012-2512-x","article-title":"Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure","volume":"58","author":"Singh","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","article-title":"High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial","volume":"64","author":"Larsen","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"21","key":"10.1016\/j.jhepr.2020.100149_bib116","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2169\/internalmedicine.45.1799","article-title":"A\u00a0recovery case of acute-onset autoimmune hepatitis presenting as fulminant hepatic failure, who received living donor-liver transplantion","volume":"45","author":"Takahashi","year":"2006","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib117","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1872-034X.2010.00755.x","article-title":"Autoimmune fulminant liver failure in adults: experience in a Japanese center","volume":"41","author":"Fujiwara","year":"2011","journal-title":"Hepatol Res"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib118","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00535-017-1394-2","article-title":"Nationwide survey for acute liver failure and late-onset hepatic failure in Japan","volume":"53","author":"Nakao","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib119","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/hepr.12344","article-title":"Pregnant woman with non-comatose autoimmune acute liver failure in the second trimester rescued using medical therapy: a case report","volume":"45","author":"Sato","year":"2015","journal-title":"Hepatol Res"},{"issue":"12","key":"10.1016\/j.jhepr.2020.100149_bib120","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/jhbp.399","article-title":"Infectious complications, steroid use and timing for emergency liver transplantation in acute liver failure: analysis in a Japanese center","volume":"23","author":"Yasui","year":"2016","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib121","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/lt.24347","article-title":"Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States","volume":"22","author":"Reddy","year":"2016","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib122","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2007.08.018","article-title":"Living donor liver transplantation for acute liver failure: a 10-year experience in a single center","volume":"206","author":"Ikegami","year":"2008","journal-title":"J\u00a0Am Coll Surg"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib123","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.transproceed.2007.02.030","article-title":"Liver transplantation for autoimmune hepatitis: a single-center experience","volume":"39","author":"Khalaf","year":"2007","journal-title":"Transplant Proc"},{"issue":"10","key":"10.1016\/j.jhepr.2020.100149_bib124","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","author":"Montano-Loza","year":"2009","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100149_bib125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib126","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib127","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0041-1345(03)00591-8","article-title":"Liver transplantation for autoimmune hepatitis: fulminant vs. chronic hepatitis presentation","volume":"35","author":"N\u00fa\u00f1ez-Mart\u00ednez","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhepr.2020.100149_bib128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2015.08.017","article-title":"\u201cDe novo\u201d and \u201crecurrent\u201d autoimmune hepatitis after liver transplantation: a comprehensive review","volume":"66","author":"Kerkar","year":"2016","journal-title":"J\u00a0Autoimmun"},{"issue":"4 Pt 1","key":"10.1016\/j.jhepr.2020.100149_bib129","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100149_bib130","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"issue":"9100","key":"10.1016\/j.jhepr.2020.100149_bib131","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100149_bib132","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s10620-012-2179-3","article-title":"Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib133","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/lt.25375","article-title":"Recurrent and De Novo Autoimmune Hepatitis","volume":"25","author":"Stirnimann","year":"2019","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib134","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"Krishnamoorthy","year":"2016","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib135","first-page":"138","article-title":"Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure","volume":"11","author":"Porta","year":"1990","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib136","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0168-8278(02)00182-4","article-title":"Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States","volume":"37","author":"Czaja","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib137","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/tropej\/49.6.367","article-title":"Our experience with fulminant hepatic failure in Turkish children: etiology and outcome","volume":"49","author":"Aydo\u01e7du","year":"2003","journal-title":"J\u00a0Trop Pediatr"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100149_bib138","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.MPG.0000158524.30294.E2","article-title":"Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United Kingdom","volume":"40","author":"Lee","year":"2005","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib139","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3476(05)82892-6","article-title":"Autoimmune hepatitis with initial presentation as acute hepatic failure in young children","volume":"116","author":"Maggiore","year":"1990","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib140","first-page":"175","article-title":"Risk factors for fulminant hepatic failure and their relation with outcome in children","volume":"60","author":"Latif","year":"2010","journal-title":"J\u00a0Pak Med Assoc"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100149_bib141","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/MEG.0b013e328353750c","article-title":"Autoimmune hepatitis in children: an overview of the disease focusing on current therapies","volume":"24","author":"Della Corte","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib142","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MPG.0b013e3181a1c265","article-title":"Autoimmune hepatitis","volume":"49","author":"Mieli-Vergani","year":"2009","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100149_bib143","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2011.10.007","article-title":"Autoimmune liver diseases in children - what is different from adulthood?","volume":"25","author":"Mieli-Vergani","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"10","key":"10.1016\/j.jhepr.2020.100149_bib144","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/MEG.0000000000000413","article-title":"Serological markers of autoimmunity in children with hepatitis A","volume":"27","author":"Abdel-Ghaffar","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100149_bib145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.hbpd.2019.08.004","article-title":"Acute onset of autoimmune hepatitis in children and adolescents","volume":"19","author":"Smolka","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100149_bib146","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100149_bib147","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MPG.0b013e3182349a04","article-title":"Pediatric end-stage liver disease score in acute liver failure to assess poor prognosis","volume":"54","author":"Sanchez","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920300835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920300835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:26:49Z","timestamp":1762900009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555920300835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":147,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2589555920300835"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100149","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to the patient with acute severe autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100149"}}